Literature DB >> 11429394

Disturbance of the prejunctional modulation of cholinergic neurotransmission during chronic granulomatous inflammation of the mouse ileum.

J G De Man1, T G Moreels, B Y De Winter, J J Bogers, E A Van Marck, A G Herman, P A Pelckmans.   

Abstract

The effect of chronic granulomatous inflammation of the intestine was studied on the prejunctional modulation of cholinergic nerve activity in the mouse ileum. Contractions to carbachol (0.01 - 0.3 microM) and to electrical field stimulation (EFS, 0.25 - 8 Hz) of enteric neurons were higher in inflamed ileum as compared to control ileum. However, when the neurally-mediated contractions to EFS were expressed as percentage of the direct smooth muscle contraction to carbachol, the responses to EFS were similar in control and inflamed ileum. Atropine (1 microM) abolished all contractions to EFS and carbachol in control and inflamed ileum. DMPP (3 - 30 microM), a nicotinic receptor agonist, induced concentration-dependent contractions that were more pronounced in inflamed ileum as compared to control ileum. Hexamethonium (100 microM), a nicotinic receptor blocker, significantly inhibited the contractions to EFS in inflamed ileum but not in control ileum. In control ileum, histamine (10 - 100 microM) and the histamine H(1) receptor agonist HTMT (3 - 10 microM) inhibited the contractions to EFS concentration-dependently without affecting the contractions to carbachol. The inhibitory effect of histamine and HTMT was prevented by the histamine H(1) antagonist mepyramine (5 - 10 microM) but not by the H(2)- and H(3)-receptor antagonists cimetidine and thioperamide (both 10 microM). In chronically inflamed ileum however, histamine (10 - 100 microM) and HTMT (3 - 10 microM) failed to inhibit the contractions to EFS. The histamine H(2) and H(3) receptor agonists dimaprit and R(-)-alpha-methylhistamine did not affect the contractions to EFS in control and inflamed ileum. The alpha(2)-receptor agonist UK 14.304 (0.01 - 0.1 microM) inhibited the contractions to EFS in control and inflamed ileum without affecting the contractions to carbachol. The effect of UK 14.304 was reversed by the alpha(2)-receptor antagonist yohimbine (1 microM). The inhibitory effect of UK 14.304 on contractions to EFS was of similar potency in control and inflamed ileum. Our results suggest that the prejunctional modulation of cholinergic nerve activity by nicotinic and histaminic H(1) receptors is disturbed during chronic intestinal inflammation whereas the modulation by alpha(2)-receptors is preserved. Such a disturbance of cholinergic nerve activity may contribute to the motility disturbances that are often observed during chronic intestinal diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429394      PMCID: PMC1572829          DOI: 10.1038/sj.bjp.0704115

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Effects of prolonged exposure to histamine on guinea pig intestinal neurons.

Authors:  K Tamura; J D Wood
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

2.  Alterations in histamine receptors of guinea-pig ileal smooth muscle produced during agonist-induced desensitization.

Authors:  S Horio; S Nakamura; Y Ishida
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

3.  Effects of histamine H1-, H2- and H3-receptor selective drugs on the mechanical activity of guinea-pig small and large intestine.

Authors:  R Leurs; M M Brozius; M J Smit; A Bast; H Timmerman
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  Histamine H3 receptors regulate acetylcholine release from the guinea pig ileum myenteric plexus.

Authors:  E Poli; G Coruzzi; G Bertaccini
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

5.  The role of histamine H1, H2 and H3 receptors on enteric ascending synaptic transmission in the guinea pig ileum.

Authors:  A A Izzo; M Costa; N Mascolo; F Capasso
Journal:  J Pharmacol Exp Ther       Date:  1998-12       Impact factor: 4.030

6.  Relationship between mast cell degranulation and jejunal myoelectric alterations in intestinal anaphylaxis in rats.

Authors:  M J Fargeas; V Theodourou; J Fioramonti; L Bueno
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

7.  Histamine release from gut mast cells from patients with inflammatory bowel diseases.

Authors:  H Nolte; N Spjeldnaes; A Kruse; B Windelborg
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

Review 8.  Innervation of mucosal immune cells in the gastrointestinal tract.

Authors:  R H Stead
Journal:  Reg Immunol       Date:  1992 Mar-Apr

9.  Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus.

Authors:  A Töröcsik; F Oberfrank; H Sershen; A Lajtha; K Nemesy; E S Vizi
Journal:  Eur J Pharmacol       Date:  1991-09-24       Impact factor: 4.432

10.  Characterization of histamine H3-receptors in guinea-pig ileum with H3-selective ligands.

Authors:  R W Hew; C R Hodgkinson; S J Hill
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

View more
  11 in total

1.  Differential role of tachykinin NK3 receptors on cholinergic excitatory neurotransmission in the mouse stomach and small intestine.

Authors:  J G De Man; B Y De Winter; H U De Schepper; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

2.  CB1 and TRPV1 receptors mediate protective effects on colonic electrophysiological properties in mice.

Authors:  A Sibaev; F Massa; B Yüce; G Marsicano; H A Lehr; B Lutz; B Göke; H D Allescher; M Storr
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

3.  Control of enteric neuromuscular functions by purinergic A(3) receptors in normal rat distal colon and experimental bowel inflammation.

Authors:  L Antonioli; M Fornai; R Colucci; N Ghisu; M Tuccori; O Awwad; A Bin; C Zoppellaro; I Castagliuolo; R M Gaion; M C Giron; C Blandizzi
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  alpha- and beta-adrenergic receptor mechanisms in spontaneous contractile activity of rat ileal longitudinal smooth muscle.

Authors:  Roland Seiler; Andreas Rickenbacher; Sidney Shaw; Bruno M Balsiger
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

5.  The endogenous cannabinoid system protects against colonic inflammation.

Authors:  Federico Massa; Giovanni Marsicano; Heike Hermann; Astrid Cannich; Krisztina Monory; Benjamin F Cravatt; Gian-Luca Ferri; Andrei Sibaev; Martin Storr; Beat Lutz
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

6.  Role of selective alpha and beta adrenergic receptor mechanisms in rat jejunal longitudinal muscle contractility.

Authors:  Roland Seiler; Andreas Rickenbacher; Sidney Shaw; Simon Haefliger; Bruno M Balsiger
Journal:  J Gastrointest Surg       Date:  2007-09-19       Impact factor: 3.452

7.  Adenosine 2B receptors (A(2B)AR) on enteric neurons regulate murine distal colonic motility.

Authors:  Bindu P Chandrasekharan; Vasantha L Kolachala; Guillaume Dalmasso; Didier Merlin; Katya Ravid; Shanthi V Sitaraman; Shanthi Srinivasan
Journal:  FASEB J       Date:  2009-04-08       Impact factor: 5.191

8.  Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation.

Authors:  Joris G De Man; Tom C Seerden; Benedicte Y De Winter; Eric A Van Marck; Arnold G Herman; Paul A Pelckmans
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  Significance of changes of gastrointestinal peptides in blood and ileum of experimental spleen deficiency rats.

Authors:  Li-Sheng Li; Rui-Yao Qu; Wei Wang; Hua Guo
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

10.  Increased cholinergic contractions of jejunal smooth muscle caused by a high cholesterol diet are prevented by the 5-HT4 agonist--tegaserod.

Authors:  Ronald Mathison; Eldon Shaffer
Journal:  BMC Gastroenterol       Date:  2006-02-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.